Cas9 Polyclonal antibody 26758-1-AP proteintech

$149.00
In stock
SKU
26758-1-AP
Catalog No.SizePrice (USD)
26758-1-AP-20UL20 μL$149.00
26758-1-AP-150UL150 μL$449.00
Catalog Number26758-1-AP
SynonymsdCas9, nCas9, Cas9 7A9, CRISPR, CRISPR/Cas9
HostRabbit
Reactivitybacteria and More (1)
Reactivitybacteria, human
FormLiquid
FormulationPBS, Azide, Glycerol
ApplicationsWB, IP, ELISA
Host / IsotypeRabbit / IgG
Tested Applications — Positive WB detected inHeLa cells transfected with CRISPR-Cas9 , A431 cells transfected with CRISPR-Cas9
Tested Applications — Positive IP detected inHeLa cells transfected with CRISPR-Cas9
Recommended Dilutions — Western Blot (WB)WB : 1:1000-1:8000
Recommended Dilutions — Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Positive WB detected inHeLa cells transfected with CRISPR-Cas9 , A431 cells transfected with CRISPR-Cas9
Positive IP detected inHeLa cells transfected with CRISPR-Cas9
Western Blot (WB)WB : 1:1000-1:8000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Tested Reactivitybacteria
Cited Reactivityhuman
ClassPolyclonal
TypeAntibody
ImmunogenCatNo: Ag25281 Product name: Recombinant Cas9 protein Source: e coli. -derived, PET30a Tag: 6*His Domain: 1-100 aa of NP_269215 Sequence: MDKKYSIGLDIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHR Predict reactive species
Full NameCas9
Calculated Molecular Weight160 kDa
GenBank Accession NumberNP_269215
RRIDAB_2918109
ConjugateUnconjugated
Purification MethodAntigen affinity purification
UNIPROT IDQ99ZW2
Storage BufferPBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA.
IP protocol for Cas9 antibody 26758-1-APDownload protocol
WB protocol for Cas9 antibody 26758-1-APDownload protocol
humanWB Oncol Lett Genome-wide CRISPR screening identifies CLDN1 as a central node in the anticancer mechanisms of berberine and as a therapeutic target in lung cancer. Authors - Xiaogang Wang View Article
Kiara (Verified Customer) (07-28-2025)This primary antibody is not validated for IF, but I gave it a shot anyways. As expected, it did not give a reliable signal. Applications: Immunofluorescence Primary Antibody Dilution: 1:400 Cell Tissue Type: iPSC-derived cardiomyocytes Cas9 Antibody Immunofluorescence validation (1:400 dilution) in iPSC-derived cardiomyocytes (Cat no:26758-1-AP)
Citations9
DilutionsWB : 1:1000-1:8000 IP : 0.5-4.0 ug for IP and 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate for WB
IsotypeIgG
ClonalityPolyclonal
Clone Number-
ConjugationUnconjugated

Cas9 (CRISPR associated protein 9) is an RNA-guided DNA endonuclease enzyme associated with the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) adaptive immunity system in Streptococcus pyogenes. This antibody detects the sp Cas9. This antibody can recognize Cas9 protein with point mutations, such as dCas9 and nCas9. Protocols Product Specific Protocols IP protocol for Cas9 antibody 26758-1-AP Download protocol WB protocol for Cas9 antibody 26758-1-AP Download protocol Standard Protocols Click here to view our Standard Protocols

Publications

  1. Enhancer release and retargeting activates disease-susceptibility genes.
    Journal: Nature | Authors: Soohwan Oh | Application: WB
  2. Enhancing Prime Editing Efficiency Through Modulation of Methylation on the Newly Synthesized DNA Strand and Prolonged Expression
    Journal: Adv Sci (Weinh) | Authors: Xiaosong Han | Species: human | Application: WB
  3. E2F1 combined with LINC01004 super-enhancer to promote hepatocellular carcinoma cell proliferation and metastasis
    Journal: Clin Epigenetics | Authors: Jingxuan Li | Species: human | Application: WB
  4. Advancing targeted protein degradation: pLIRTAC's role in glioma and CAR-T cell therapy.
    Journal: Autophagy | Authors: Kunjian Lei | Species: human | Application: WB
  5. TRIM27-Cas9-loaded EVs suppress HCC proliferation and enhance responsiveness to anti-PD-1 therapy by promoting ACSL4-mediated ferroptosis
    Journal: Cell Death Differ | Authors: Jie Wen | Species: human | Application: WB
  6. Genome-wide CRISPR screening identifies CLDN1 as a central node in the anticancer mechanisms of berberine and as a therapeutic target in lung cancer.
    Journal: Oncol Lett | Authors: Xiaogang Wang | Species: human | Application: WB
  7. Genome-wide CRISPR screen reveals PEX11B as a host restriction factor against ORFV through membrane fluidity regulation.
    Journal: PLoS Pathog | Authors: Xiaoran Gao
  8. Targeting the HERV-K102 envelope elicits pyroptosis and represents a novel therapeutic strategy for acute myeloid leukemia.
    Journal: Blood Res | Authors: Lihong Zong | Species: human | Application: WB
  9. Genome-wide CRISPR screening identifies CLDN1 as a central node in the anticancer mechanisms of berberine and as a therapeutic target in lung cancer.
    Journal: Oncol Lett | Authors: Xiaogang Wang | Species: human | Application: WB

Product Documents

Datasheet

Datasheet

Reviews

Write Your Own Review
You're reviewing:Cas9 Polyclonal antibody 26758-1-AP proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.